Mach7 Technologies Ltd (ASX: M7T) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Mach7 Technologies Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Mach7 Technologies Ltd (ASX: M7T)
Latest News
Share Market News
ASX 200 rises 0.4%
Share Market News
Here's why the Mach7 (ASX:M7T) share price just reached a multi-year high
Share Gainers
Why IDP Education, Lake Resources, Mach7, & Tyro shares are shooting higher
Share Gainers
Why the Mach7 (ASX:M7T) share price is surging 8% higher today
⏸️ ASX Shares
2 fantastic ASX healthcare shares to buy
⏸️ ASX Shares
Fundie names 5 ASX shares with good growth prospects
⏸️ ASX Shares
Wilson Asset Management thinks these 2 small cap ASX shares are a buy
Speculative
2 growing small cap ASX shares to watch in 2021
Speculative
2 small cap ASX healthcare shares to watch
Speculative
2 exciting small cap ASX shares to watch closely in 2021
Share Gainers
Why the Mach7 (M7T) share price is closing in on a record high today
Speculative
2 exciting small cap ASX shares to buy
Frequently Asked Questions
-
No, this ASX small-cap share has never paid dividends.
-
Mach7 Technologies has been listed on the ASX since 30 November 2005.
M7T ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Mach7 Technologies Ltd
Mach7 Technologies Ltd (ASX: M7T) is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organisations. Its systems create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. This allows healthcare enterprises to identify, connect, and share diagnostic image and patient care intelligence.
Mach7 has more than 150 customers in 15 countries and derives a majority of its revenue from North America.
M7T Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
27 Mar 2024 | $0.70 | $0.01 | 1.45% | 109,249 | $0.70 | $0.70 | $0.68 |
26 Mar 2024 | $0.69 | $0.00 | 0.00% | 287,077 | $0.69 | $0.69 | $0.68 |
25 Mar 2024 | $0.69 | $0.01 | 1.47% | 255,729 | $0.67 | $0.69 | $0.66 |
22 Mar 2024 | $0.68 | $0.00 | 0.00% | 80,129 | $0.68 | $0.68 | $0.67 |
21 Mar 2024 | $0.68 | $0.01 | 1.49% | 118,117 | $0.67 | $0.68 | $0.67 |
20 Mar 2024 | $0.67 | $-0.01 | -1.47% | 498,510 | $0.70 | $0.70 | $0.65 |
19 Mar 2024 | $0.68 | $-0.02 | -2.86% | 122,226 | $0.70 | $0.71 | $0.68 |
18 Mar 2024 | $0.70 | $-0.01 | -1.42% | 31,144 | $0.72 | $0.72 | $0.70 |
15 Mar 2024 | $0.71 | $0.01 | 1.43% | 14,976 | $0.70 | $0.71 | $0.70 |
14 Mar 2024 | $0.70 | $-0.01 | -1.41% | 195,707 | $0.70 | $0.71 | $0.70 |
13 Mar 2024 | $0.71 | $0.01 | 1.42% | 164,791 | $0.70 | $0.73 | $0.70 |
12 Mar 2024 | $0.71 | $0.00 | 0.00% | 1,545,723 | $0.71 | $0.71 | $0.70 |
11 Mar 2024 | $0.71 | $-0.01 | -1.41% | 17,014 | $0.72 | $0.72 | $0.70 |
08 Mar 2024 | $0.71 | $0.01 | 1.42% | 190,521 | $0.70 | $0.71 | $0.69 |
07 Mar 2024 | $0.71 | $0.00 | 0.00% | 161,936 | $0.71 | $0.72 | $0.69 |
06 Mar 2024 | $0.71 | $-0.02 | -2.78% | 79,288 | $0.72 | $0.72 | $0.71 |
05 Mar 2024 | $0.72 | $0.02 | 2.84% | 317,497 | $0.70 | $0.73 | $0.69 |
04 Mar 2024 | $0.71 | $0.01 | 1.44% | 189,799 | $0.69 | $0.71 | $0.68 |
01 Mar 2024 | $0.70 | $0.03 | 4.51% | 28,694 | $0.68 | $0.70 | $0.68 |
29 Feb 2024 | $0.67 | $-0.01 | -1.49% | 530,079 | $0.68 | $0.71 | $0.67 |
28 Feb 2024 | $0.67 | $-0.01 | -1.47% | 89,702 | $0.68 | $0.68 | $0.67 |
27 Feb 2024 | $0.68 | $-0.02 | -2.86% | 248,698 | $0.70 | $0.71 | $0.68 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
01 Dec 2023 | Eliot Siegel | Issued | 25,000 | $18,125 |
Issue of options.
|
01 Dec 2023 | Robert Bazzani | Issued | 25,000 | $18,125 |
Issue of options.
|
23 Nov 2023 | Mike Lampron | Issued | 700,000 | $434,000 |
Issue of securities. 1,825,185 Performance Rights
|
17 Nov 2023 | Mike Lampron | Issued | 325,000 | $234,000 |
Issue of securities.
|
01 Nov 2023 | Eliot Siegel | Buy | 225,000 | $54,900 |
Exercise of options.
|
01 Nov 2023 | Eliot Siegel | Exercise | 225,000 | $54,900 |
Exercise of options. As per announcement on 06-11-2023
|
21 Sep 2023 | Mike Lampron | Sell | 89,810 | $65,381 |
As advised by the company. Disposal of shares under sell-to-cover arrangement
|
21 Sep 2023 | Mike Lampron | Issued | 350,000 | $255,500 |
Exercise of options.
|
21 Sep 2023 | Mike Lampron | Exercise | 350,000 | $255,500 |
Exercise of options. As per announcement on 22-09-2023
|
29 Jun 2023 | David Chambers | Exercise | 225,000 | $54,900 |
Exercise of options.
|
29 Jun 2023 | David Chambers | Buy | 225,000 | $54,900 |
Exercise of options.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Dr Eliot L Siegel | Non-Executive Director | Aug 2018 |
Dr Siegel is known thought leader in the world of radiology and imaging informatics and artificial intelligence applications in medicine. He is currently Professor and Vice Chair of information systems at the University of Maryland School of Medicine, Department of Diagnostic Radiology, and the Chief of Radiology and Nuclear Medicine for the Veterans Affairs Maryland Healthcare System, both in Baltimore, MD as well as adjunct professor of computer science and biomedical engineering at the undergraduate campuses of the University of Maryland. Under his guidance, the VA Maryland Healthcare System became the first filmless healthcare enterprise in the World. He has written over 300 articles and book chapters about PACS (Picture Archiving and Communication Systems) and digital imaging, and has edited six books on the topic, including Filmless Radiology and Security Issues in the Digital Medical Enterprise. He has given more than 1,000 presentations throughout the world on a broad range of topics involving the use of computers in medicine and artificial intelligence. Dr. Siegel was symposium chairman for the Society of Photo-optical and Industrial Engineers (SPIE) Medical Imaging Meeting for three years and has been honored as a fellow in that organisation as well as the American College of Radiology. He is also a Board member of Carestream Health, a billion-dollar global company in digital radiography and computed radiography systems and serves on numerous advisory boards in medical imaging.He is Member of Risk Committee.
|
Mr Mike Lampron | Chief Operating OfficerChief Executive OfficerManaging Director | Mar 2019 |
Mr Lampron is the CEO of Mach7 Technologies. With over 20 years of experience in business and operational management for Healthcare IT companies, Mike brings a experience ranging from private start-up organisations as well as established companies such as IBM and GE. Mike was previously the Chief Executive Officer for a National Teleradiology Company and has a proven ability to drive results through a combination of astute analysis, innovative execution and crossfunctional teamwork. Michael is responsible for our customers' success while driving excellence throughout Mach7.
|
Mr Robert John Bazzani | Non-Executive Director | Jan 2020 |
Mr Bazzani spent 20 years with the global consulting firm KPMG, where he rose to the top and served as Chairman of KPMG Victoria, National Managing Partner for KPMG Australia's Enterprise Division and National Managing Partner for KPMG's M&A Division. Whilst in these roles, Rob was a member of KPMG's National Executive Committee (NEC), which oversees and is responsible for the Firm's turnover, strategic decision making, profitability and operations. Rob has a demonstrated track record of leading and growing scale and complex businesses. He has played a role in advising clients (public, private, and global subsidiaries) on commercial maters, public transitions, corporate governance, investment banking and law, M&A and has engaged with Government and Regulators. With experience in corporate advisory, Rob has deep commercial and industry knowledge across financial services, asset and wealth management, technology, property, insurances and consumer & industrial markets. He is Chair of Risk Committee.
|
Mr Peter Gundy | Non-Executive Director | Nov 2023 |
--
|
Ms Rebecca Thompson | Non-Executive Director | Nov 2023 |
--
|
Mr Tony Panther | Company Secretary | Feb 2023 |
-
|
Tony Panther | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Sandhurst Trustees Ltd (Jmfg Consol A/C) | 34,943,767 | 14.54% |
National Nominees Limited | 33,728,744 | 14.04% |
J P Morgan Nominees Australia Pty Limited | 26,127,926 | 10.87% |
Hsbc Custody Nominees (Australia) Limited | 12,558,036 | 5.23% |
Citicorp Nominees Pty Limited | 9,220,511 | 3.84% |
Lawn Views Pty Ltd (Angela Williams Family A/C) | 6,363,394 | 2.65% |
Pt Dwi Satrya Utama | 4,392,959 | 1.83% |
UBS Nominees Pty Ltd | 4,022,984 | 1.67% |
Perco Group Pty Ltd (F S P A/C) | 4,000,000 | 1.66% |
Padmalwar Prakash | 3,569,921 | 1.49% |
Chew & Partners (Import & Export) Pte Ltd | 2,900,074 | 1.21% |
Moggs Creek Pty Ltd (Moggs Creek Super A/C) | 2,639,345 | 1.10% |
Albert Liong Pak-Fai | 2,044,189 | 0.85% |
Bpnt Pty Ltd (The Heaney Family Super A/C) | 2,000,000 | 0.83% |
Bpnt Pty Ltd (The Heaney Family Sf A/C) | 1,921,218 | 0.80% |
Microequities Asset Management Pty Ltd (Microeqts Nanocap No 11 A/C) | 1,751,702 | 0.73% |
Supernatural Super Pty Ltd (The Supernatural Super A/C) | 1,684,000 | 0.70% |
Mr Ravindran Krishnan | 1,636,422 | 0.68% |
Bnp Paribas Noms Pty Ltd (Drp) | 1,467,677 | 0.61% |
Ty Webb Pty Ltd (Ty Webb A/C) | 1,339,444 | 0.56% |